NASDAQ:CORT

Corcept Therapeutics Stock Insider Trading

etoro logo Buy CORT
*Your capital is at risk
$114.49
-3.83 (-3.24%)
At Close: Jul 31, 2026

Corcept Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -71.45. In total, the insiders bought 1.13M and sold 1.75M CORT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-71.45
Buy 1.13M shares
Sell 1.75M shares
51% Buy Activity
Weak Negative Correlation
Sell Signal Medium Confidence
May 27, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -71.45.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 05, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guyer William
Chief Development Officer
Officer 20 000
Value: $433.0K
May 05, 2026
Buy
Common Stock
M-Exempt
Guyer William
Chief Development Officer
Officer 20 000
Value: $433.0K
May 05, 2026
Sell
Common Stock
S-Sale
Guyer William
Chief Development Officer
Officer 20 000
Value: $1.04M
May 01, 2026
Sell
Common Stock
S-Sale
Belanoff Joseph K
Chief Executive Officer
CEO / President 40 000
Value: $2.00M
Apr 22, 2026
Sell
Common Stock
G-Gift
Wilson James N
Director
Director 2 000
Value: $0
Apr 07, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guyer William
Chief Development Officer
Officer 20 000
Value: $433.0K
Apr 07, 2026
Buy
Common Stock
M-Exempt
Guyer William
Chief Development Officer
Officer 20 000
Value: $433.0K
Apr 07, 2026
Sell
Common Stock
S-Sale
Guyer William
Chief Development Officer
Officer 20 000
Value: $819.4K
Apr 06, 2026
Sell
Common Stock
G-Gift
Wilson James N
Director
Director 5 000
Value: $0
Mar 25, 2026
Sell
Common Stock
S-Sale
Belanoff Joseph K
Chief Executive Officer
CEO / President 26 198
Value: $1.31M
Mar 20, 2026
Sell
Common Stock
S-Sale
Guyer William
Chief Development Officer
Officer 11 767
Value: $423.7K
Mar 20, 2026
Sell
Common Stock
G-Gift
Wilson James N
Director
Director 4 000
Value: $0
Mar 20, 2026
Buy
Common Stock
M-Exempt
Guyer William
Chief Development Officer
Officer 11 767
Value: $254.8K
Mar 20, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guyer William
Chief Development Officer
Officer 11 767
Value: $254.8K
Mar 17, 2026
Buy
Common Stock
P-Purchase
Baker G Leonard Jr
Director
Director 75 782
Value: $2.50M
Mar 17, 2026
Buy
Common Stock
P-Purchase
Baker G Leonard Jr
Director
Director 24 218
Value: $812.8K
Mar 13, 2026
Sell
Common Stock
F-InKind
Mahoney David L
Director
Director 5 469
Value: $175.8K
Mar 13, 2026
Buy
Stock Option (right to buy)
M-Exempt
Mahoney David L
Director
Director 30 000
Value: $175.8K
Mar 13, 2026
Sell
Common Stock
G-Gift
Wilson James N
Director
Director 28 000
Value: $0
Mar 13, 2026
Buy
Common Stock
M-Exempt
Mahoney David L
Director
Director 30 000
Value: $175.8K
Mar 13, 2026
Buy
Common Stock
J-Other
Mahoney David L
Director
Director 24 531
Value: $788.7K
Mar 13, 2026
Sell
Common Stock
G-Gift
Mahoney David L
Director
Director 24 531
Value: $0
Mar 04, 2026
Buy
Common Stock
M-Exempt
Guyer William
Chief Development Officer
Officer 8 233
Value: $178.2K
Mar 04, 2026
Sell
Common Stock
S-Sale
Guyer William
Chief Development Officer
Officer 8 233
Value: $296.3K
Mar 04, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guyer William
Chief Development Officer
Officer 8 233
Value: $178.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CORCEPT THERAPEUTICS INCORPORATED
Corcept Therapeutics
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE